pharmaphorum

MARCH 8, 2022

How did you get into life sciences? Dr Doina Ionescu (DI): After completing my PhD in physics at the University of Southampton, I joined Merck as a research scientist in 1998. DI: Transitioning from being a research scientist to a mergers & acquisitions project manager was not easy. What has your career path been?

Life Science 98

Life Science Engineer Scientist Doctors 98

Drug Discovery Today

OCTOBER 27, 2022

27, Vilnius will host the EFIB’2022 event which will bring the European life science sector together. In the field of life sciences, Lithuania is best known for the discovery of gene scissors by Prof. Lab, focused on research and development of novel genome editing tools. Virginijus Šikšnys.

Genome 85

Genome Genomics Gene Editing Life Science 85

pharmaphorum

SEPTEMBER 12, 2022

Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. Tailored oncology.

Genome 105

Genome Genomics Clinical Trials Clinical Trials 105

BioTech 365

FEBRUARY 23, 2021

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →

Life Science 40

Life Science Genome Genomics Licensing 40

BioTech 365

JANUARY 10, 2022

Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development NASHVILLE, Tenn.–(BUSINESS

Life Science 40

Life Science Genome Genomics Development 40

XTalks

MAY 23, 2024

One of the more intriguing developments in cancer research in recent years is the growing understanding of clonal hematopoiesis, a phenomenon where blood cells expand from a single clone due to genetic mutations. Clonal hematopoiesis increases in prevalence with age and can precede hematologic malignancies.

Genetics 114

Genetics Research Genome Genomics 114

Drug Discovery Today

MAY 26, 2023

BARCELONA/LONDON, 25.05.23: Seqera Labs, the leading provider of secure workflow orchestration software in the life sciences sector, has partnered with Genomics England, the government-owned company that launched the 100,000 Genomes Project in partnership with the NHS.

Genome 45

Genome Genomics Genome Project Research 45

pharmaphorum

MAY 6, 2022

The PING Conference 2022 is back in person this year, with opportunities to network face-to-face with people from right across the life sciences ecosystem. Hear about how the UK is leading the way in what has been described as the ‘Golden Age for Life Sciences Innovation’ and the opportunities arising from this from leading experts.

Life Science 52

Life Science Genome Genomics Production 52

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Generation of strong research dataset cohorts must begin with high-quality clinical samples. Partnerships and Establishing Research Cohorts.

Research 98

Research Biobanking Drugs Genome 98

pharmaphorum

JULY 26, 2021

The most complete database of protein structures ever assembled, developed with the help of Google’s artificial intelligence unit DeepMind, has been made freely available to researchers around the world. Around a third of the structures are considered to be detailed and precise enough to allow drug design. Demis Hassabis.

Protein 130

Protein Genome Genomics Life Science 130

pharmaphorum

JANUARY 19, 2022

Research into single-cell sequencing has been boosted with Single Cell Discoveries and BioTuring joining forces to refine the process. A rapidly growing field of research, single-cell RNA sequencing is vital for those working in areas such as oncology, immunology, and neuroscience.

RNA 72

RNA Research Life Science Bioinformatics 72

XTalks

MAY 22, 2024

John Finn, PhD Chief Scientific Officer Tome Biosciences Dr. Finn has over 20 years of experience in the gene therapy space with a focus on genome editing and delivery technologies. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Gene Editing 52

Gene Editing Life Science Gene Gene Therapy 52

pharmaphorum

OCTOBER 7, 2021

The answer to the problem, of course, lays in making medical research more effective. However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. Far more common than initially thought, rare disease treatments remain far too scarce. About IQVIA.

Genome 98

Genome Genomics Medicine Life Science 98

The Pharma Data

JANUARY 31, 2021

(NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Genome 52

Genome Genomics Life Science DNA 52

XTalks

MARCH 21, 2025

Lee Honigberg on the Future of Blood-Based Biomarker Assays GeneDX GeneDX recently integrated AI (Multiscore) into its interpretation platform, improving speed and accuracy in analyzing complex genomic data. 10x Genomics 10x Genomics reported $707 million in 2024 revenue.

Genome 59

Genome Genomics FDA Approval Trials 59

Drug Discovery Today

OCTOBER 27, 2022

27, Vilnius will host the EFIB’2022 event which will bring the European life science sector together. In the field of life sciences, Lithuania is best known for the discovery of gene scissors by Prof. Lab, focused on research and development of novel genome editing tools. Virginijus Šikšnys.

Genome 40

Genome Genomics Gene Editing Life Science 40

Roots Analysis

AUGUST 28, 2022

The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.

Genome 52

Genome Genomics RNA Genome Project 52

BioTech 365

JULY 27, 2021

Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations HERCULES, Calif.–(BUSINESS NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, … Continue reading →

Genome 40

Genome Genomics Life Science Production 40

Pharmaceutical Technology

JUNE 8, 2023

Data in clinical trials For example, huge amounts of data can be mined from electronic health records (EHRs) and other sources to optimise clinical research, from drug identification to treatment plan design. When it is properly utilised, this information can be used to improve patient outcomes.

Clinical Research 130

Clinical Research Research Clinical Trials Clinical Trials 130

XTalks

FEBRUARY 1, 2021

Montreal, Canada-based Caprion Biosciences announced last week that the clinical research organization (CRO) will rebrand as CellCarta. The move follows the 2019 merger between Caprion and HistoGeneX , a Belgian histopathology and genomics lab.

Life Science 98

Life Science Branding Genome Genomics 98

pharmaphorum

JULY 5, 2022

I recently had the pleasure of attending the PING Conference 2022 , which had the tagline of ‘The Golden Age for Life Sciences Innovation’. Aspirations for the UK in life sciences. Faster access for patients for interventions. Data on all aspects, including stratification of patient types.

Life Science 98

Life Science Medicine Biobanking Research 98

Drug Discovery Today

AUGUST 5, 2021

HumGut comprises a collection of about 30,000 genomes, covering the broad diversity of bacterial genomes found in the human gut. This work is funded by the Norwegian University of Life Sciences (NMBU) and GA with support from the Research Council of Norway through an Industrial PhD program.

Genetic Analysis 40

Genetic Analysis Genome Genomics Genetics 40

XTalks

MAY 20, 2022

Do you possess laboratory skills, an analytical mindset and a penchant for research? A clinical scientist conducts research to help prevent illness and develops techniques to support patient diagnosis and treatment. They will often find themselves working in a healthcare or pharmaceutical field that supports human health research.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

XTalks

DECEMBER 14, 2022

Expanding upon the CRISPR-Cas9 gene editing system, researchers at MIT have designed a new technique called PASTE gene editing that can cut out defective genes and replace them with new genes in a safer and more efficient way. The MIT research team turned to a family of enzymes called integrases to meet their goal.

Gene Editing 98

Gene Editing DNA Gene Gene Sequencing 98

XTalks

AUGUST 29, 2022

CRISPR is notable for engineering living cells, allowing scientists to edit, turn off, delete, or replace genes in a cell’s genome. It is difficult to control where the viral vectors insert genes in the genome, and it is difficult to manufacture large quantities of clinical-grade viral vectors. From the Bench to Patient Therapeutics.

Gene Editing 98

Gene Editing DNA Gene Genome 98

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

APRIL 8, 2022

This is where modern technologies and data-driven medical informatics can bridge gaps in RD research. . The webinar will also cover: How the necessary routine and research data can be collected in registries in a further processable form by patients and healthcare professionals.

Genome 78

Genome Genomics Research Big Data 78

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.

Genome 105

Genome Genomics Research Medicine 105

XTalks

SEPTEMBER 9, 2021

It was found that the gene being delivered through the therapy had integrated into the genomes of six of the seven mice that were administered the highest dose. Although a rare event that occurs at very low frequency, AAV vectors can integrate into genomes through homologous recombination.

Gene Therapy 105

Gene Therapy Gene Genome Genomics 105

XTalks

MARCH 7, 2024

Other issues include medical systems that can often be dismissive of women’s health concerns or experiences, and historically less research on women’s health, which together, can lead to late diagnoses or misdiagnoses. Through this, researchers can pinpoint breast cancer cell types and their phenotypic states.

Genetics 115

Genetics Hormones Genome Genomics 115

XTalks

MAY 22, 2024

Exact Sciences (Overall Rank 281) Exact Sciences , founded in 1995, is a molecular diagnostics company specializing in early cancer screening and diagnostic tests. Exact Sciences is also investing in its pipeline to develop innovative solutions before, during and after a cancer diagnosis. Thermo Fisher Scientific boasts a $42.86

Life Science 95

Life Science Production FDA Approval Development 95

XTalks

MAY 10, 2022

CancerVar will help researchers standardize and automate clinical interpretations for 13 million somatic mutations from 1,911 cancer census genes. The gene mutations that cause sporadic cancer occur only in the tumor cells and are acquired during an individual’s life, not inherited. What is CancerVar? Why Was CancerVar Developed?

Bioinformatics 98

Bioinformatics Development Gene Genome 98

XTalks

AUGUST 21, 2024

XTALKS WEBINAR: Accelerating Neurodegenerative Clinical Drug Development with AI Live and On-Demand: Wednesday, September 18, 2024, at 11am EDT (4pm BST/UK) Register for this webinar today to gain insights into how AI is playing a crucial role in advancing CNS research related to neurodegenerative clinical drug development.

Drugs 111

Drugs Genome Genomics Clinical Trials 111

XTalks

FEBRUARY 27, 2024

Rare Disease Day 2024, which falls on February 29 this year, is an opportunity to unite under a common cause: to bring attention to the challenges faced by those living with rare diseases and to push for advancements in research, treatment and policy. The FDA introduced its Orphan Drug Act in 1983.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

XTalks

AUGUST 5, 2020

In recent webinars by Genuity Science, formerly known as WuXi NextCODE, experts from the biotech and pharma industries spoke about leveraging the power of single cell RNA sequencing platforms and solutions in conjunction with machine learning technologies such as AI in cell biology and disease research. Chromium Single Cell Solutions.

Gene Expression 112

Gene Expression Development RNA Drugs 112

pharmaphorum

OCTOBER 6, 2022

So, when a new disease emerges, researchers have a near-impossible task working upstream from symptoms to identify the underlying cause and biological mechanisms causing disease. This problem is compounded when researchers are presented with a complex set of symptoms, with no easily identifiable infectious agent as the cause.

In-Vivo 98

In-Vivo Research Genetics Drugs 98

The Pharma Data

SEPTEMBER 28, 2020

. Accenture Applied Intelligence announced a new data and analytics approach to manage and derive insights from paediatric acute myeloid leukaemia (AML) genomic data, with the potential to improve precision medicine. And for some people, that treatment worked.

Genome 52

Genome Genomics Clinical Trials Clinical Trials 52